# Pre-Treatment DCE-MRI AI Models Predict Neoadjuvant Chemotherapy Response in HR+/HER2- Breast Cancer

> **NCT07702708** · — · RECRUITING · sponsor: **Fujian Cancer Hospital** · enrollment: 100 (estimated)

## Conditions studied

- HR+/HER2- Breast Cancer
- Breast Neoplasms

## Interventions

- **DIAGNOSTIC_TEST:** Pre-treatment DCE-MRI-based AI model

## Key facts

- **NCT ID:** NCT07702708
- **Lead sponsor:** Fujian Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-04-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07702708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07702708, "Pre-Treatment DCE-MRI AI Models Predict Neoadjuvant Chemotherapy Response in HR+/HER2- Breast Cancer". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07702708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*